In this episode, co-host Andreas Seas interviews Jon Nelson who shares his experience with deep brain stimulation for treatment-resistant depression. Listen as he shares about the hope this treatment approach gave him and how DBS has transformed his life. This treatment remains investigational, but with the studies underway that can help patients like Jon, we can start to understand the profound impact it can have.
All content for ASSFN Podcast is the property of ASSFN and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode, co-host Andreas Seas interviews Jon Nelson who shares his experience with deep brain stimulation for treatment-resistant depression. Listen as he shares about the hope this treatment approach gave him and how DBS has transformed his life. This treatment remains investigational, but with the studies underway that can help patients like Jon, we can start to understand the profound impact it can have.
Contract Negotiation and Rising the Ranks to Leadership with Dr. Dario Englot and Dr. Shabbar Danish
ASSFN Podcast
35 minutes
3 months ago
Contract Negotiation and Rising the Ranks to Leadership with Dr. Dario Englot and Dr. Shabbar Danish
In this podcast episode, cohosts Danika Paulo and Andreas Seas and featured guest speakers Dr. Dario Englot (Associate Professor of Neurosurgery at Vanderbilt University Medical Center, ASSFN Board Member) and Dr. Shabbar Danish (Chairman and Professor of Neurosurgery at Hackensack-Meridian, ASSFN Board Member) discuss nuances of job contract negotiation as well as advice for rising the ranks to academic and organizational leadership. We discuss differences in academic vs. private practice jo...
ASSFN Podcast
In this episode, co-host Andreas Seas interviews Jon Nelson who shares his experience with deep brain stimulation for treatment-resistant depression. Listen as he shares about the hope this treatment approach gave him and how DBS has transformed his life. This treatment remains investigational, but with the studies underway that can help patients like Jon, we can start to understand the profound impact it can have.
